There’s lots to like here
“If we are able to see positive signs that AMP945 improves the leading current treatment option we will commence discussions with regulators and potential partners concerning future trials required to support product approval.”
Positive signs ...
This trial will be conducted in newly diagnosed patients receiving first-line therapy for pancreatic cancer.
Looking forward to getting these trials underway ...
.
Ann: Phase 2 Trial in First-Line Pancreatic Cancer Patients, page-4
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.0¢ |
Change
0.005(3.45%) |
Mkt cap ! $41.21M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 16.0¢ | 15.0¢ | $55.88K | 361.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 94946 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 56159 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| ATX (ASX) Chart |